Taken together, these data suggest that a partial restoration of Nexilin expression is sufficient to mitigate cardiomyopathy and indicate that the premature or perinatal lethality of gKO mice is mainly attributed to the absence of Nexilin in cardiomyocytes rather than in other tissues. This evidence concerns the gene NEXN and cardiomyopathy.